Beverly A. Teicher

802 total citations
32 papers, 665 citations indexed

About

Beverly A. Teicher is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Beverly A. Teicher has authored 32 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Beverly A. Teicher's work include Cancer, Hypoxia, and Metabolism (10 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Treatment and Pharmacology (4 papers). Beverly A. Teicher is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Treatment and Pharmacology (4 papers). Beverly A. Teicher collaborates with scholars based in United States. Beverly A. Teicher's co-authors include Emil Frei, John S. Lazo, Alakananda Basu, Hideya Takeuchi, Sylvia A. Holden, Roy S. Herbst, Jennifer Flatow, C Wheeler, James M. Crawford and Krishna Menon and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Beverly A. Teicher

32 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beverly A. Teicher United States	15	387	240	133	79	57	32	665
Robert Alan Nagourney United States	17	432 1.1×	312 1.3×	129 1.0×	101 1.3×	34 0.6×	39	937
Kenji Kitazato Japan	17	319 0.8×	296 1.2×	101 0.8×	157 2.0×	60 1.1×	33	812
Wayne D. Klohs United States	16	456 1.2×	249 1.0×	89 0.7×	59 0.7×	37 0.6×	33	728
Andrew McGown United Kingdom	11	325 0.8×	228 0.9×	111 0.8×	37 0.5×	41 0.7×	28	661
Jean‐Claude Marshall United States	18	440 1.1×	251 1.0×	87 0.7×	112 1.4×	48 0.8×	31	782
Annemarie Larkin Ireland	18	477 1.2×	318 1.3×	148 1.1×	60 0.8×	45 0.8×	32	770
Eric Brouwer Netherlands	16	384 1.0×	664 2.8×	82 0.6×	93 1.2×	43 0.8×	21	1.1k
Nicola Dobbs United Kingdom	15	367 0.9×	378 1.6×	122 0.9×	95 1.2×	27 0.5×	26	899
John W. Madsen United States	10	469 1.2×	89 0.4×	160 1.2×	105 1.3×	45 0.8×	11	791
Hisao Fukumoto Japan	17	587 1.5×	432 1.8×	129 1.0×	193 2.4×	58 1.0×	30	1.0k

Countries citing papers authored by Beverly A. Teicher

Since Specialization

Citations

This map shows the geographic impact of Beverly A. Teicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly A. Teicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly A. Teicher more than expected).

Fields of papers citing papers by Beverly A. Teicher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly A. Teicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly A. Teicher. The network helps show where Beverly A. Teicher may publish in the future.

Co-authorship network of co-authors of Beverly A. Teicher

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly A. Teicher. A scholar is included among the top collaborators of Beverly A. Teicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly A. Teicher. Beverly A. Teicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dexheimer, Thomas S., Nathan P. Coussens, Thomas Silvers, et al.. (2025). Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids. SLAS DISCOVERY. 32. 100222–100222. 2 indexed citations

Coussens, Nathan P., Thomas S. Dexheimer, Li Chen, et al.. (2025). Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids. SLAS DISCOVERY. 33. 100230–100230. 1 indexed citations

Teicher, Beverly A.. (1998). Role of angiogenesis in the response to anticancer therapies. Drug Resistance Updates. 1(1). 59–61. 7 indexed citations

Teicher, Beverly A., et al.. (1998). Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 42(1). 24–30. 15 indexed citations

Herbst, Roy S., Hideya Takeuchi, & Beverly A. Teicher. (1998). Paclitaxel/carboplatin administration along with antiangiogenic therapy in non-small-cell lung and breast carcinoma models. Cancer Chemotherapy and Pharmacology. 41(6). 497–504. 51 indexed citations

Teicher, Beverly A., Gulshan Ara, & David Northey. (1997). Interaction of interleukin-11 (rhIL-11) with cytotoxic therapies in the human HT-29 colon carcinoma. International Journal of Oncology. 10(6). 1081–5. 1 indexed citations

Palayoor, Sanjeewani T., Edward A. Bump, Beverly A. Teicher, & C. Norman Coleman. (1997). Apoptosis and Clonogenic Cell Death in PC3 Human Prostate Cancer Cells after Treatment with Gamma Radiation and Suramin. Radiation Research. 148(2). 105–105. 24 indexed citations

Teicher, Beverly A., et al.. (1996). Interaction of interleukin-11 with cytotoxic therapiesin vitro against CEM cells andin vivo against EMT-6 murine mammary carcinoma. International Journal of Cancer. 67(6). 864–870. 6 indexed citations

Holden, Sylvia A., Beverly A. Teicher, Michael F. Robinson, David Northey, & A. Rosowsky. (1995). Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo. Cancer Chemotherapy and Pharmacology. 36(2). 165–171. 14 indexed citations

10.

Ara, Gulshan, et al.. (1994). cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.. PubMed. 54(6). 1497–502. 17 indexed citations

11.

Teicher, Beverly A., et al.. (1993). Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor. Journal of Cancer Research and Clinical Oncology. 119(11). 645–651. 10 indexed citations

12.

Schwartz, Gary N., et al.. (1993). Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine. Cancer Chemotherapy and Pharmacology. 32(6). 455–462. 11 indexed citations

13.

Teicher, Beverly A., et al.. (1992). Enhancement of Fractionated Radiation Therapy by an Experimental Concentrated Perflubron Emulsion (Oxygent®) in the Lewis Lung Carcinoma. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 899–902. 10 indexed citations

14.

Crawford, James M., et al.. (1991). Physical and biological properties of fluorescent dansylated bile salt derivatives: the role of steroid ring hydroxylation. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1085(2). 223–234. 9 indexed citations

15.

Tanaka, Juichi, Beverly A. Teicher, Terence S. Herman, et al.. (1991). Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo. International Journal of Cancer. 48(4). 631–637. 6 indexed citations

16.

Holden, Sylvia A., Beverly A. Teicher, & Terence S. Herman. (1991). Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in fsaiic fibrosarcoma. International Journal of Radiation Oncology*Biology*Physics. 20(5). 1031–1038. 3 indexed citations

17.

Herman, Terence S., et al.. (1990). Effect of Acidic pH on Radiosensitization of FSallC Cells in Vitro by Misonidazole, Etanidazole, or cis-Diamminedichloroplatinum (II). Radiation Research. 124(1). 28–28. 8 indexed citations

18.

Teicher, Beverly A., et al.. (1989). Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.. PubMed. 49(3). 595–8. 34 indexed citations

19.

Teicher, Beverly A., et al.. (1988). Effect of Fluosol-DA® on the response of intracranial 9L tumors to X rays and BCNU. International Journal of Radiation Oncology*Biology*Physics. 15(5). 1187–1192. 26 indexed citations

20.

Rosowsky, A., J E Wright, Carol A. Cucchi, et al.. (1987). Collateral methotrexate resistance in cultured human head and neck carcinoma cells selected for resistance to cis-diamminedichloroplatinum(II).. PubMed. 47(22). 5913–8. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact